Esophageal cancer is the 6th leading cause of cancer-related mortality worldwide with a
fiveyear overall survival of less than 25%. 1, 2 Patients rarely present at an early stage as …

Background and purpose More than 40% of patients with esophageal squamous cell
carcinoma (ESCC) exhibit pathological complete responses (pCR) after neoadjuvant …

Background The comparative effectiveness of trimodality therapy vs definitive
chemoradiation for treating locally advanced esophageal cancer in older adults is uncertain …

Methods An online electronic search of all eligible literature through PubMed, Google
Scholar, and the Cochrane Library database was conducted using a combination of the …

Purpose Definitive chemoradiotherapy (dCRT) is a treatment option with curative intent for
patients with esophageal cancer that could result in late toxicities and affect health-related …

Surgery after neoadjuvant chemoradiotherapy remains the gold standard for the treatment of
resectable esophageal cancer (EC); however, chemoradiotherapy without surgery has been …

Esophageal cancer has a poor prognosis. For locally advanced tumors, neoadjuvant
chemoradiation followed by esophagectomy (trimodal therapy) and definitive …

Introduction Oesophageal cancer survival is reported by epidemiological studies, but
knowledge on survival trends regarding different histologies and operative treatment status …

Radiotherapy has been used as a substitute for surgery or to alleviate symptoms in patients
who are unfit to undergo surgical treatment. However, the clinical outcomes of radiation …

Zusammenfassung Hintergrund Die Strahlentherapie ist ein integraler Bestandteil in den
meisten modernen multimodalen Tumortherapiekonzepten sowohl in kurativen als auch in …